Fifth Third Bancorp’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-357
Closed -$35.1K 2668
2025
Q2
$35.1K Buy
357
+9
+3% +$852 ﹤0.01% 1558
2025
Q1
$32.2K Buy
348
+141
+68% +$13K ﹤0.01% 1587
2024
Q4
$18.8K Sell
207
-112
-35% -$10.3K ﹤0.01% 1767
2024
Q3
$30.8K Buy
319
+2
+0.6% +$195 ﹤0.01% 1621
2024
Q2
$29.1K Buy
317
+29
+10% +$2.69K ﹤0.01% 1592
2024
Q1
$26.5K Buy
288
+18
+7% +$1.69K ﹤0.01% 1583
2023
Q4
$25.7K Sell
270
-7
-3% -$654 ﹤0.01% 1677
2023
Q3
$25.9K Sell
277
-800
-74% -$73.9K ﹤0.01% 1637
2023
Q2
$98.5K Sell
1,077
-200
-16% -$16.4K ﹤0.01% 1153
2023
Q1
$93.9K Sell
1,277
-183
-13% -$15.8K ﹤0.01% 1221
2022
Q4
$122K Sell
1,460
-191
-12% -$17.2K ﹤0.01% 1076
2022
Q3
$160K Buy
1,651
+47
+3% +$5.61K ﹤0.01% 989
2022
Q2
$169K Sell
1,604
-102
-6% -$13K ﹤0.01% 998
2022
Q1
$294K Buy
1,706
+799
+88% +$119K ﹤0.01% 876
2021
Q4
$147K Buy
907
+317
+54% +$50.9K ﹤0.01% 1113
2021
Q3
$88K Buy
590
+3
+0.5% +$624 ﹤0.01% 1217
2021
Q2
$144K Sell
587
-12
-2% -$3.15K ﹤0.01% 1070
2021
Q1
$159K Buy
599
+196
+49% +$55.3K ﹤0.01% 1015
2020
Q4
$118K Sell
403
-44
-10% -$11.3K ﹤0.01% 1099
2020
Q3
$106K Sell
447
-34
-7% -$7.73K ﹤0.01% 1099
2020
Q2
$95K Sell
481
-95
-16% -$17.7K ﹤0.01% 1110
2020
Q1
$106K Sell
576
-25
-4% -$4.45K ﹤0.01% 1029
2019
Q4
$100K Buy
601
+179
+42% +$26.6K ﹤0.01% 1160
2019
Q3
$55K Buy
422
+21
+5% +$2.73K ﹤0.01% 1317
2019
Q2
$49K Buy
+401
New +$47.6K ﹤0.01% 1348
2016
Q1
Sell
-79
Closed -$3K 2314
2015
Q4
$3K Buy
79
+1
+1% +$40 ﹤0.01% 2319
2015
Q3
$3K Buy
78
+17
+28% +$717 ﹤0.01% 2449
2015
Q2
$2K Buy
61
+1
+2% +$31 ﹤0.01% 2534
2015
Q1
$2K Buy
+60
New +$1.69K ﹤0.01% 2437

Other funds holding AMED

Fifth Third Bancorp's AMED Position: Q3 2025 in Review

Fifth Third Bancorp sold out of Amedisys (AMED) in Q3 2025, closing a stake of 357 shares — an estimated $35.1K sold.

Fifth Third Bancorp first reported a position in AMED in Q1 2015 and held it in 29 quarters. The position peaked at $294K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Fifth Third Bancorp reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 357 Amedisys shares in Q3 2025, an estimated $35.1K.
  • Fifth Third Bancorp first reported a position in Amedisys in Q1 2015 and held it in 29 quarters.
  • Fifth Third Bancorp's Amedisys position peaked at $294K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.